A recent ľֱ "Clinical Challenges" series on metabolic dysfunction-associated steatohepatitis (MASH; formerly nonalcoholic steatohepatitis, or NASH) tackled the need to raise patient/physician awareness of the increasing prevalence of the liver disease, lifestyle approaches to managing affected patients of all ages, and promising treatments in the pipeline.
The following is a three-question quiz to test your knowledge on each aspect of the series. Correct answers and explanations appear after completing the quiz.
![author['full_name']](https://clf1.medpagetoday.com/media/images/author/KKneisel_188.jpg)